EFFECT OF SHORT ADMINISTRATION BISPHOSPHONATE TO PERIOSTEUM AND SINUS MEMBRANE AFTER ILIAC BONE GRAFT INTO MAXILLARY SINUS IN RABBIT
![]() |
Lim, Kwang-Soo
(Department of Oral and Maxillofacial Surgery, Pusan Paik hospital, Inje University)
Seo, Go-Eun (Department of Oral and Maxillofacial Surgery, Pusan Paik hospital, Inje University) Song, Jun-Ho (Department of Oral and Maxillofacial Surgery, Pusan Paik hospital, Inje University) Lee, Soo-Woon (Department of Oral and Maxillofacial Surgery, Pusan Paik hospital, Inje University) Park, Sang-Jun (Department of Oral and Maxillofacial Surgery, Pusan Paik hospital, Inje University) |
1 | Jensen OT, Shulman LB, Block MS. : Report of trhe sinus consensus conference of 1996. Int J Oral Maxillofac Implants. 13: 11, 1998. |
2 | Roelofs AJ, Thompson K, Gordon S. : Molecular Mechanism of Action of Bisphosphonates : CurrentStatus. Clin Cancer Res. 15: 6222s, 2006. |
3 | Fettetti G, Fabi A, CarliniP et al. : Zoledronic-acid induced circulating level modifications of angiogenic factors, metalloproteinases and proinflammatory cytokines in metastatic breast cancer patients. Oncology. 69: 35, 2005. DOI ScienceOn |
4 | Boyne P J, James R A, : Grafting of the maxillary sinus floor with autogenous marrow and bone. J Oral Surg 38: 613, 1980. |
5 | Pampu AA, Dolanmaz D, Tuz HH et al.: Histomophometric Evaluation of the Effects of Zoledronic Acid on Mandibular Distraction Osteogenesis in Rabbits. J Oral Maxillofac Surg. 66: 905, 2008. DOI ScienceOn |
6 | Cetinkaya BO, Keles GC, Ayas B et al.: Effects of Risedronate on alveolar bone loss and angiogenesis: A Sterologic study in Rats. J Periodontol 79: 1950, 2008. DOI ScienceOn |
7 | Konstantinos N, Malizos, Loukia K.: The healing potential of the periosteum Molecular aspects. Int. J. Care Injured 36: S13, 2005. |
8 | Goran Augustin, Anko Antabak, Slavko Davila.: The periosteum Part1: Anatomy.histology and molecular biology. Int. J Care Injured 38: 1115, 2007. DOI |
9 | Wood J, Bonj ean K, Ruetz et al.: Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302: 1055, 2002. DOI ScienceOn |
10 | Bezzi M, Hasmim M, Bieler G et al.: Zoledronate sensitizes endothelial cells to tumor necrosis factor-induced programmed cell death; Evidence for the suppression of sustained activation of focal adhesion kinase and protein kinase B/Akt. J Biol Chem 278: 43603, 2003. DOI |
11 | Altundal H.Guvener O.: The effect of aledronate on resorption of the alveolar bone following tooth extraction. Int J Oral Maxillofac Surg. 33: 286, 2004. DOI ScienceOn |
12 | Landeberg R, Cozin M. Cremers S et al.: Inhibition of Oral Mucosal Cell Wound Healing by Bisphosphonates. J Oral Maxillofac Surg 66: 839, 2008. DOI ScienceOn |
13 | Marx RE,Fortin M,Broumand V,: Bisphosphonate-induced exposed bone (osteonerosis/osteopetrosis) of the jaws: Risk factors,recognition,prevention and treatment. J Oral Maxillofacial Surg 63: 1567, 2005. DOI ScienceOn |
14 | American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-related Osteonecrosis of the Jaws. J Oral Maxillofac Surg 65: 369, 2007. DOI |
15 | Hoff AO, Toth BB, Altundag V et al,: Osteonecrosis of the jaw in patients receiving intravenous bisphosphonate therapy. 2006 ASCO Annual meeting precedings Part I. J Clin Oncol 24: 8528, 2006. |
16 | Murad OM, Arora S, Farag AF et al.:. Bisphosphonates and osteonecrosis of the jaw: a retrospective study. Endocr Pract. 13: 232, 2007. DOI ScienceOn |
17 | Ruggiero SL, Mehrotra B, Rosenberg TJ et al.: Osteonecrosis of the jaws associated with the use of bisphosphonates ; A review of 63 cases. J Oral Maxillofac Surg 62: 527, 2004 . DOI ScienceOn |
18 | Van Poznak CH,: The use of bisphosphonates in patients with breast cancer. Cancer control 9: 480, 2002. DOI |
19 | Costa L, Lipton A, Coleman RE: .Role of bisphosphonates for the management of skeletal complications and bone pain from skeletal metastases. Support Cancer Ther. 3 : 143, 2006. DOI |
20 | Rosen LS, Gordon D. Kaminski M et al,: Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer of osteolytic lesions of multiple myeloma: A phase III. double-blind,comparative trial. Cancer J 7: 377, 2001. |
21 | Menezes AM, Rocha FA, Chaves HV. : Effect of sodium aledronate on alveolar bone resorption in experimental periodontitis in rats. J Periodontol 76: 1901, 2005. DOI ScienceOn |
22 | Mitsuta T, Horiuchi H. Shinoda H. : Effects of topical administration of clodronate on alveolar bone resorption in rats with experimental periodontitis. J Periodontol 73: 479, 2002. DOI ScienceOn |
23 | Tatum H.: Maxillary and sinus implant reconstructions. Dent Clin North Am. 30: 207, 1986 . |
![]() |